| Dr Mark Lewis Epstein, MD | |
|
2211 Lomas Blvd Ne, Albuquerque, NM 87106-2719 | |
| (505) 272-0010 | |
| Not Available |
| Full Name | Dr Mark Lewis Epstein |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 11 Years |
| Location | 2211 Lomas Blvd Ne, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730525742 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD2018-0143 (New Mexico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Presbyterian Shadyside | Pittsburgh, PA | Hospital |
| Upmc Northwest | Seneca, PA | Hospital |
| Magee Womens Hospital Of Upmc Health System | Pittsburgh, PA | Hospital |
| Upmc Hamot Hospital | Erie, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regional Health Services Inc | 4880593722 | 484 |
| University Of Pittsburgh Physicians | 8729990239 | 3721 |
News Archive
Halozyme Therapeutics, Inc. today announced that it is offering to sell 8.3 million shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering
GlycoVaxyn AG, a leader in the development of innovative vaccines, announced today that the Phase I study of its Shigella dysenteriae bioconjugate vaccine has been completed and met the primary and secondary endpoints: demonstration of safety and immunogenicity.
"[M]ore than 200 delegates ranging from policymakers and representatives of development agencies to global health practitioners and civil society members" are gathering in India this week for a national summit on the "Call to Action for Child Survival and Development," IIP Digital reports.
Drug safety remains front and center for the U.S. Food and Drug Administration as the agency strives to improve the public's perception of the organization. Likewise, the pharmaceutical industry is focused on improving its reputation among consumers and recognizes that its diligence in the reporting of adverse events plays an important role in that effort.
The U.S. Agriculture Department (USDA) has now formally closed its investigation of the first native U.S. case of mad cow disease, in June this year.
› Verified 8 days ago
| Entity Name | Regional Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174520654 PECOS PAC ID: 4880593722 Enrollment ID: O20040108000694 |
News Archive
Halozyme Therapeutics, Inc. today announced that it is offering to sell 8.3 million shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering
GlycoVaxyn AG, a leader in the development of innovative vaccines, announced today that the Phase I study of its Shigella dysenteriae bioconjugate vaccine has been completed and met the primary and secondary endpoints: demonstration of safety and immunogenicity.
"[M]ore than 200 delegates ranging from policymakers and representatives of development agencies to global health practitioners and civil society members" are gathering in India this week for a national summit on the "Call to Action for Child Survival and Development," IIP Digital reports.
Drug safety remains front and center for the U.S. Food and Drug Administration as the agency strives to improve the public's perception of the organization. Likewise, the pharmaceutical industry is focused on improving its reputation among consumers and recognizes that its diligence in the reporting of adverse events plays an important role in that effort.
The U.S. Agriculture Department (USDA) has now formally closed its investigation of the first native U.S. case of mad cow disease, in June this year.
› Verified 8 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
Halozyme Therapeutics, Inc. today announced that it is offering to sell 8.3 million shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering
GlycoVaxyn AG, a leader in the development of innovative vaccines, announced today that the Phase I study of its Shigella dysenteriae bioconjugate vaccine has been completed and met the primary and secondary endpoints: demonstration of safety and immunogenicity.
"[M]ore than 200 delegates ranging from policymakers and representatives of development agencies to global health practitioners and civil society members" are gathering in India this week for a national summit on the "Call to Action for Child Survival and Development," IIP Digital reports.
Drug safety remains front and center for the U.S. Food and Drug Administration as the agency strives to improve the public's perception of the organization. Likewise, the pharmaceutical industry is focused on improving its reputation among consumers and recognizes that its diligence in the reporting of adverse events plays an important role in that effort.
The U.S. Agriculture Department (USDA) has now formally closed its investigation of the first native U.S. case of mad cow disease, in June this year.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Lewis Epstein, MD 933 Bradbury Dr Se Ste 2222, Albuquerque, NM 87106-4375 Ph: () - | Dr Mark Lewis Epstein, MD 2211 Lomas Blvd Ne, Albuquerque, NM 87106-2719 Ph: (505) 272-0010 |
News Archive
Halozyme Therapeutics, Inc. today announced that it is offering to sell 8.3 million shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering
GlycoVaxyn AG, a leader in the development of innovative vaccines, announced today that the Phase I study of its Shigella dysenteriae bioconjugate vaccine has been completed and met the primary and secondary endpoints: demonstration of safety and immunogenicity.
"[M]ore than 200 delegates ranging from policymakers and representatives of development agencies to global health practitioners and civil society members" are gathering in India this week for a national summit on the "Call to Action for Child Survival and Development," IIP Digital reports.
Drug safety remains front and center for the U.S. Food and Drug Administration as the agency strives to improve the public's perception of the organization. Likewise, the pharmaceutical industry is focused on improving its reputation among consumers and recognizes that its diligence in the reporting of adverse events plays an important role in that effort.
The U.S. Agriculture Department (USDA) has now formally closed its investigation of the first native U.S. case of mad cow disease, in June this year.
› Verified 8 days ago
Mark Ehrhart, MD Radiology Medicare: Medicare Enrolled Practice Location: Msc 10 5550, 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-4661 | |
Dr. Shaya Ansari, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 8020 Constitution Pl Ne Ste 202, Albuquerque, NM 87110 Phone: 505-998-3096 Fax: 505-998-3100 | |
Dr. Karen Renee Craig, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2211 Lomas Blvd Ne, Albuquerque, NM 87106 Phone: 505-272-0011 | |
Erika Jane Starks, MD, PHD Radiology Medicare: Medicare Enrolled Practice Location: Radiology Msc 10-5530 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-6225 | |
Stuart Bernard Paster, Radiology Medicare: Not Enrolled in Medicare Practice Location: 8020 Constitution Place Ne, #101, Albuquerque, NM 87110 Phone: 505-998-1317 Fax: 505-998-1308 | |
Danielle Eckart Sorte, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: Dept Of Radiology Msc 10 5530, 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 801-641-5515 | |
Dr. Luis Centenera, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4411 The 25 Way Ne, Suite 150, Albuquerque, NM 87109 Phone: 505-332-5800 Fax: 505-332-6919 |